|
1
|
Vairaktaris E, Yapijakis C, Wiltfang J, et
al: Are factor V and prothrombin mutations associated with
increased risk of oral cancer? Anticancer Res. 25:2561–2565.
2005.PubMed/NCBI
|
|
2
|
Van Hemelrijck M, Adolfsson J, Garmo H, et
al: Risk of thromboembolic diseases in men with prostate cancer:
results from the population-based PCBaSe Sweden. Lancet Oncol.
11:450–458. 2010.
|
|
3
|
Trikha M and Nakada MT: Platelets and
cancer: implications for antiangiogenic therapy. Semin Thromb
Hemost. 28:39–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baade PD, Youlden DR and Krnjacki LJ:
International epidemiology of prostate cancer: geographical
distribution and secular trends. Mol Nutr Food Res. 53:171–184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeegers MP, Jellema A and Ostrer H:
Empiric risk of prostate carcinoma for relatives of patients with
prostate carcinoma: a meta-analysis. Cancer. 97:1894–1903. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eeles RA, Kote-Jarai Z, Giles GG, et al:
Multiple newly identified loci associated with prostate cancer
susceptibility. Nat Genet. 40:316–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramacciotti E, Wolosker N, Puech-Leao P,
et al: Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu
and MTHFR C677T polymorphisms in cancer patients with and without
venous thrombosis. Thromb Res. 109:171–174. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eroglu A, Egin Y, Cam R and Akar N: The
19-bp deletion of dihydrofolate reductase (DHFR),
methylenetetrahydrofolate reductase (MTHFR) C677T, factor V Leiden,
prothrombin G20210A polymorphisms in cancer patients with and
without thrombosis. Ann Hematol. 88:73–76. 2009. View Article : Google Scholar
|
|
9
|
Ozkan M, Sivgin S, Kocyigit I, et al: Do
thrombophilic gene mutations have a role on thromboembolic events
in cancer patients? Asia Pac J Clin Oncol. 8:e34–e41. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pectasides D, Pectasides E, Papaxoinis G,
et al: Combination chemotherapy with docetaxel, vinorelbine and
estramustine phosphate in metastatic androgen-resistant prostate
cancer: a single institution experience. Anticancer Res.
29:769–775. 2009.
|
|
11
|
Bourdoumis A, Papatsoris AG, Chrisofos M,
Efstathiou E, Skolarikos A and Deliveliotis C: The novel prostate
cancer antigen 3 (PCA3) biomarker. Int Braz J Urol. 36:665–669.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hansel DE, DeMarzo AM, Platz EA, et al:
Early prostate cancer antigen expression in predicting presence of
prostate cancer in men with histologically negative biopsies. J
Urol. 177:1736–1740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kennedy DA, Stern SJ, Matok I, et al:
Folate intake, MTHFR polymorphisms, and the risk of colorectal
cancer: a systematic review and meta-analysis. J Cancer Epidemiol.
2012:9525082012.PubMed/NCBI
|
|
14
|
Ozdemir S, Silan F, Hasbek Z, et al:
Increased T-allele frequency of 677 C>T polymorphism in the
methylenetetrahydrofolate reductase gene in differentiated thyroid
carcinoma. Genet Test Mol Biomarkers. 16:780–784. 2012.
|
|
15
|
Izmirli M, Inandiklioglu N, Abat D, et al:
MTHFR gene polymorphisms in bladder cancer in the Turkish
population. Asian Pac J Cancer Prev. 12:1833–1835. 2011.PubMed/NCBI
|
|
16
|
Jakubowska A, Rozkrut D, Antoniou A, et
al: Association of PHB 1630 C>T and MTHFR 677 C>T
polymorphisms with breast and ovarian cancer risk in BRCA1/2
mutation carriers: results from a multicenter study. Br J Cancer.
106:2016–2024. 2012.
|
|
17
|
Kang BS, Ahn DH, Kim NK and Kim JW:
Relationship between metabolic syndrome and MTHFR polymorphism in
colorectal cancer. J Korean Soc Coloproctol. 27:78–82. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shannon B, Gnanasampanthan S, Beilby J and
Iacopetta B: A polymorphism in the methylenetetrahydrofolate
reductase gene predisposes to colorectal cancers with
microsatellite instability. Gut. 50:520–524. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vossen CY, Hoffmeister M, Chang-Claude JC,
Rosendaal FR and Brenner H: Clotting factor gene polymorphisms and
colorectal cancer risk. J Clin Oncol. 29:1722–1727. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pihusch R, Danzl G, Scholz M, et al:
Impact of thrombophilic gene mutations on thrombosis risk in
patients with gastrointestinal carcinoma. Cancer. 94:3120–3126.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arslan S, Manduz S, Epozturk K, Karahan O
and Akkurt I: Association of deep venous thrombosis with
prothrombotic gene polymorphism identified in lung cancer cases.
Mol Biol Rep. 38:2395–2400. 2011. View Article : Google Scholar : PubMed/NCBI
|
